|4Mar 2, 3:04 PM ET

ORAMED PHARMACEUTICALS INC. 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Mar 2, 2017

Insider Transaction Report

Form 4
Period: 2017-02-09
Transactions
  • Award

    Stock Option (right to buy)

    2017-02-09+4,0844,084 total
    Exercise: $1.00Exp: 2027-02-09Common Stock (4,084 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest immediately.

Documents

1 file
  • 4
    f4020917friedman_oramed.xmlPrimary

    OWNERSHIP DOCUMENT